European Commission grants marketing authorisation for pazopanib (Votrient®)
7 August 2012 | By GlaxoSmithKline
The European Commission has granted pazopanib marketing authorisation...
List view / Grid view
News
Lilly announces study results regarding postmenopausal women with back pain caused by vertebral fractures
7 August 2012 | By Eli Lilly and Company
Eli Lilly and Company announced data from a Phase III trial...
Abbott’s Omnilink Elite® Vascular Balloon-Expandable Stent System receives FDA approval
7 August 2012 | By Abbott
The U.S. FDA has approved the Omnilink Elite® Vascular Balloon-Expandable Stent System...
Pfizer announces co-primary clinical endpoints not met in second Phase 3 Bapineuzumab Study
6 August 2012 | By Pfizer
Bapineuzumab IV Phase 3 program discontinued...
I Holland launch Die Contion Monitor
6 August 2012 | By I Holland
I Holland were very pleased by the reaction to the launch of the 'Holland Die Condition Monitor'...
Bristol-Myers Squibb Foundation awards $1.6 million in grants to help communities in India address type 2 diabetes
6 August 2012 | By Bristol-Myers Squibb Company
$1.6 million awarded in grants...
Novartis and University of Pennsylvania form broad-based R&D alliance to advance novel T-cell immunotherapies to treat cancer
6 August 2012 | By Novartis
Collaboration to study CAR technology...
GSK completes acquisition of Human Genome Sciences
3 August 2012 | By GlaxoSmithKline
GlaxoSmithKline has completed its acquisition of Human Genome Sciences for US$3.6 billion...
Study shows Toviaz is effective in reducing urge urinary incontinence in patients with overactive bladder after suboptimal response to Detrol LA
3 August 2012 | By Pfizer
Phase 4 study has met its primary endpoint...
Boehringer Ingelheim Biopharmaceuticals announces manufacturing agreement with Servier
3 August 2012 | By Boehringer Ingelheim
Boehringer Ingelheim announced an agreement with Servier & its partner XOMA Corporation...
Regulatory Update – GSK announces submissions in the EU and US for dabrafenib and trametinib
3 August 2012 | By GlaxoSmithKline
GlaxoSmithKline announced regulatory submissions in the European Union and US...
Lonza announces license agreement with iPS Academia Japan
Lonza has entered a worldwide, non-exclusive licensing agreement with iPS Academia Japan, Inc. for its induced pluripotent stem cell (iPSC) patent portfolio. By entering this agreement, Lonza demonstrates its commitment to the field of regenerative medicine and reinforces its belief that iPSCs are a key platform technology for the cell…
Teva Pharmaceutical announces new appointments
2 August 2012 | By Teva Pharmaceutical Industries Ltd
Dr. Carlo De Notaristefani appointed as President and CEO of Global Operations, and Mr. Aharon (Arik) Yaari as the Executive VP...
Gilead Sciences announces new collaboration with Indian partners
2 August 2012 | By Gilead Sciences, Inc.
Gilead Sciences, Inc., together with Mylan Laboratories, Ranbaxy Laboratories Limited and Strides Arcolab, have entered into agreements...
Bristol-Myers Squibb suspends administration of study drug in Clinical Trial of investigational NS5B nucleotide for the treatment of Hepatitis C
1 August 2012 | By Bristol-Myers Squibb Company
Administration of study drug suspended...
